Sun Pharma asks 18 top brass of Ranbaxy to resign
This comes after a year after the Dilip Shanghvi-led firm acquired Ranbaxy in an all-stock deal and the company's Q4 profits shrank 44 per cent due to costs incurred in assimilating the buyout.
Jun 18, 2015, 12:23 PM IST